Patent · US Active

Heterodimeric vascular endothelial growth factor and use thereof

US10851142B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

National Health Research Institutes · TW

Inventors

Alan Lee
Jui-Ling Tsai · Gongguan, TW

Key dates

Filing date	Dec 2, 2016
Grant date	Dec 1, 2020
Priority date	—
Expiry date	May 26, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A fusion protein, comprising: (i) a first vascular endothelial growth factor (VEGF) isoform, and (ii) a second VEGF isoform, and (iii) a dimerization domain between the first isoform and the second isoform, wherein the first isoform and the second isoform are selected from VEGF121 and VEGF165.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.